The post Ritz Crackers Recalled In Eight States Over Peanut Allergy Threat appeared on BitcoinEthereumNews.com. Topline Dozens of cases of Ritz Peanut Butter Cracker Sandwich were recalled this week after individually wrapped packs were possibly mislabeled as the cheese variety of the cracker sandwiches, according to the Food and Drug Administration, impacting eight states. Photos of the impacted products (not pictured) can be seen on the FDA’s website. Photo by Kevin Carter/Getty Images Key Facts A total of 70 cases of the peanut butter cracker sandwiches have been recalled after individually wrapped packs “may” have been mislabeled as Ritz Cheese Cracker Sandwiches, the FDA said in a statement. All outer cartons of the affected cases are labeled correctly with allergen information that says the product contains peanuts. The products included in the recall are 20 pack units that contain six-piece sleeves and have “best when used by” dates of Jan. 8, 2026 and Jan. 15, 2026. The items also have an “AE” plant code on top of the package. Photos of the impacted units can be seen on the FDA’s website, which says they were available at a limited number of retail stores as of Nov. 28. The cases were sold in New York, New Jersey, Pennsylvania, Georgia, Arkansas, Missouri, Oklahoma, and Alabama. No injuries or illness were reported to Mondelēz Global, the parent company of Ritz, as of Nov. 28. Get Forbes Breaking News Text Alerts: We’re launching text message alerts so you’ll always know the biggest stories shaping the day’s headlines. Text “Alerts” to (201) 335-0739 or sign up here. Big Number 4.6 million. That is approximately how many Americans have peanut allergies, according to a 2021 study in the Journal of Allergy and Clinical Immunology. Read More Source: https://www.forbes.com/sites/antoniopequenoiv/2025/12/03/ritz-cracker-sandwiches-recalled-after-mislabeling-poses-threat-to-those-with-peanut-allergies/The post Ritz Crackers Recalled In Eight States Over Peanut Allergy Threat appeared on BitcoinEthereumNews.com. Topline Dozens of cases of Ritz Peanut Butter Cracker Sandwich were recalled this week after individually wrapped packs were possibly mislabeled as the cheese variety of the cracker sandwiches, according to the Food and Drug Administration, impacting eight states. Photos of the impacted products (not pictured) can be seen on the FDA’s website. Photo by Kevin Carter/Getty Images Key Facts A total of 70 cases of the peanut butter cracker sandwiches have been recalled after individually wrapped packs “may” have been mislabeled as Ritz Cheese Cracker Sandwiches, the FDA said in a statement. All outer cartons of the affected cases are labeled correctly with allergen information that says the product contains peanuts. The products included in the recall are 20 pack units that contain six-piece sleeves and have “best when used by” dates of Jan. 8, 2026 and Jan. 15, 2026. The items also have an “AE” plant code on top of the package. Photos of the impacted units can be seen on the FDA’s website, which says they were available at a limited number of retail stores as of Nov. 28. The cases were sold in New York, New Jersey, Pennsylvania, Georgia, Arkansas, Missouri, Oklahoma, and Alabama. No injuries or illness were reported to Mondelēz Global, the parent company of Ritz, as of Nov. 28. Get Forbes Breaking News Text Alerts: We’re launching text message alerts so you’ll always know the biggest stories shaping the day’s headlines. Text “Alerts” to (201) 335-0739 or sign up here. Big Number 4.6 million. That is approximately how many Americans have peanut allergies, according to a 2021 study in the Journal of Allergy and Clinical Immunology. Read More Source: https://www.forbes.com/sites/antoniopequenoiv/2025/12/03/ritz-cracker-sandwiches-recalled-after-mislabeling-poses-threat-to-those-with-peanut-allergies/

Ritz Crackers Recalled In Eight States Over Peanut Allergy Threat

2025/12/04 07:52

Topline

Dozens of cases of Ritz Peanut Butter Cracker Sandwich were recalled this week after individually wrapped packs were possibly mislabeled as the cheese variety of the cracker sandwiches, according to the Food and Drug Administration, impacting eight states.

Photos of the impacted products (not pictured) can be seen on the FDA’s website.

Photo by Kevin Carter/Getty Images

Key Facts

A total of 70 cases of the peanut butter cracker sandwiches have been recalled after individually wrapped packs “may” have been mislabeled as Ritz Cheese Cracker Sandwiches, the FDA said in a statement.

All outer cartons of the affected cases are labeled correctly with allergen information that says the product contains peanuts.

The products included in the recall are 20 pack units that contain six-piece sleeves and have “best when used by” dates of Jan. 8, 2026 and Jan. 15, 2026.

The items also have an “AE” plant code on top of the package.

Photos of the impacted units can be seen on the FDA’s website, which says they were available at a limited number of retail stores as of Nov. 28.

The cases were sold in New York, New Jersey, Pennsylvania, Georgia, Arkansas, Missouri, Oklahoma, and Alabama.

No injuries or illness were reported to Mondelēz Global, the parent company of Ritz, as of Nov. 28.

Get Forbes Breaking News Text Alerts: We’re launching text message alerts so you’ll always know the biggest stories shaping the day’s headlines. Text “Alerts” to (201) 335-0739 or sign up here.

Big Number

4.6 million. That is approximately how many Americans have peanut allergies, according to a 2021 study in the Journal of Allergy and Clinical Immunology.

Read More

Source: https://www.forbes.com/sites/antoniopequenoiv/2025/12/03/ritz-cracker-sandwiches-recalled-after-mislabeling-poses-threat-to-those-with-peanut-allergies/

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

The Adoption of Web3 in Europe: Current Status, Opportunities, and Challenges

The Adoption of Web3 in Europe: Current Status, Opportunities, and Challenges

How decentralization technologies are advancing in the Old Continent.
Share
The Cryptonomist2025/12/06 15:00